Dudediligence.

Vivos Therapeutics, Inc

VVOSNASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$3.9MSep ’24$3.7MDec ’24$3.0MMar ’25$3.8MJun ’25$6.8MSep ’25$3.8MDec ’25$5.1MMar ’26$5.2MJun ’26
Net income, by quarter
−$2.6MSep ’24−$2.8MDec ’24−$3.9MMar ’25−$5.0MJun ’25−$5.4MSep ’25−$6.9MDec ’25−$7.7MMar ’26−$5.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$16.9M$16.0M$13.8M$15.0M$17.4M
Gross profit$12.6M$10.0M$8.3M$9.0M$10.5M
Operating income−$20.4M−$25.0M−$17.3M−$11.2M−$19.9M
Net income−$20.3M−$23.8M−$13.6M−$11.1M−$21.2M
Operating cash flow−$15.7M−$19.6M−$11.9M−$12.7M−$15.3M
Free cash flow−$18.1M−$20.5M−$12.7M−$13.3M−$17.6M
Cash$24.0M$3.5M$1.6M$6.3M$2.0M
Debt$1.3Mnone on filenone on filenone on file$8.8M
Shares outstanding23.0M920.6K1.8M5.9M9.3M